Cargando…

Radiation Safety and External Radiation Exposure Rate of Patients Receiving I-131 Therapy for Hyperthyroidism and Remnant Ablation as Outpatient: An Institutional Experience

Objective Our objective was to study the radiation exposure rate as function of time in the administration of radioiodine iodine-131 (I-131) for the treatment of thyrotoxicosis or Graves' disease and remnant ablation on an outpatient basis at the Department of Nuclear Medicine, and also, to st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatia, Nisha, Dhingra, Vandana K., Mittal, Pulkit, Saini, Sunil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581751/ https://www.ncbi.nlm.nih.gov/pubmed/37854087 http://dx.doi.org/10.1055/s-0043-1771285

Ejemplares similares

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
por: Sundaram, P. Shanmuga, et al.
Publicado: (2011)

Received dose variability after administration of I‐131 for treatment of hyperthyroidism in cats
por: Busser, Suzanne, et al.
Publicado: (2021)

I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
por: Lin, Rong, et al.
Publicado: (2015)

SAT452 Efficacy Of I-131 Treatment Dosage For Hyperthyroidism With Current Institution Formula
por: Salam, Sanna, et al.
Publicado: (2023)

Micronucleus frequencies in groups receiving external or internal radiation
por: Özdal, Ayşegül, et al.
Publicado: (2016)

Efficacy and Affecting Factors of (131)I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
por: Wang, Chen, et al.
Publicado: (2018)

Effects of drugs on the efficacy of radioiodine ((131)|) therapy in hyperthyroid patients
por: Oszukowska, Lidia, et al.
Publicado: (2010)

I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
por: Shengguang, Yan, et al.
Publicado: (2016)

A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period
por: Murayama, Daisuke, et al.
Publicado: (2021)

Outpatient (131)I Treatment for a Patient with Graves' Disease Receiving Hemodialysis
por: Suzuki, Miho, et al.
Publicado: (2016)

Overall Quality of Life Assessment in the Patients Undergoing External Beam Radiation in Outpatient Radiation Oncology Department
por: Koul, Rashmi, et al.
Publicado: (2015)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

The Influence of Antithyroid Drug Discontinuation to the Therapeutic Efficacy of (131)I in Hyperthyroidism
por: Kartamihardja, A. Hussein Sundawa, et al.
Publicado: (2016)

Treatment failure in hyperthyroid cats after radioiodine (I‐131) injection
por: Mullowney, Deirdre, et al.
Publicado: (2021)

Outcomes of Radioactive Iodine ((131)I) Therapy among Hyperthyroid patients
por: Khan, Muhammad Sajjad Ali, et al.
Publicado: (2023)

TSH ≥30 mU/L may not be necessary for successful (131)I remnant ablation in patients with differentiated thyroid cancer
por: Ju, Nianting, et al.
Publicado: (2023)

Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of (131)iodine treatment
por: Wang, Renfei, et al.
Publicado: (2017)

Predictors of euthyreosis in hyperthyroid patients treated with radioiodine (131)I(−): a retrospective study
por: Stachura, Albert, et al.
Publicado: (2020)

Changes in Radiosensitivity to Gamma-Rays of Lymphocytes from Hyperthyroid Patients Treated with I-131
por: Dini, Valentina, et al.
Publicado: (2022)

A practical individualized radiation precaution based on the dose rate at release time after inpatient (131)I ablation therapy
por: Han, Sangwon, et al.
Publicado: (2021)

Supernovae Remnants: Acceleration Of Particles And Search For Very High Energy Radiation
por: Völk, H
Publicado: (2001)

Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
por: Zubair Hussain, Syed, et al.
Publicado: (2014)

Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015)

I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy
por: Probst, Stephan, et al.
Publicado: (2018)

Outcome of (131)I therapy in hyperthyroidism using a 550MBq fixed dose regimen
por: Lewis, Anthony, et al.
Publicado: (2013)

SUN-510 Prolonged RAIA Induced Thyroiditis After 131 I Therapy for Graves’ Hyperthyroidism
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020)

Radioiodine Remnant Ablation: A Critical Review
por: Bal, Chandra Sekhar, et al.
Publicado: (2015)

Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation
por: Mohamed Sayed, Mohamed Hosny, et al.
Publicado: (2015)

Applied physics of external radiation exposure: dosimetry and radiation protection
por: Antoni, Rodolphe, et al.
Publicado: (2017)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation
por: McAninch, Elizabeth A, et al.
Publicado: (2023)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose
por: Wong, Ka Kit, et al.
Publicado: (2018)

The Prevalence, Magnitude, and Reversibility of Elevated Liver Enzyme Activities in Hyperthyroid Cats Presenting for Iodine-131 Treatment
por: Campbell, Joseph, et al.
Publicado: (2022)

Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
por: Li, Dan, et al.
Publicado: (2023)

Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with (131)I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
por: Signore, Alberto, et al.
Publicado: (2022)

SUN-339 External Beam Radiation Therapy Improves TGFB1-Induced Mesenchymal Stem Cell-Mediated NIS Gene (131)I Therapy
por: Schug, Christina, et al.
Publicado: (2019)

Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver
por: Mukai, Yuki, et al.
Publicado: (2019)

The Study of External Dose Rate and Retained Body Activity of Patients Receiving (131)I Therapy for Differentiated Thyroid Carcinoma
por: Zhang, Haiying, et al.
Publicado: (2014)

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)

The Effects of the Factors Related to the Patient and the Disease on the Performance of Ablation Therapy in Patients with Differentiated Thyroid Cancer who have Received I-131 Ablation Therapy
por: Şengöz, Tarık, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kctmqpjn2fcun0cphqgsc6us82